Sign In
Buy ASRT
$23.47
+0.0200 (+0.0853%)
At Close: Jun 03, 2026
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of A
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Assertio Holdings, Inc. (NASDAQ: ASRT) to Garda Therapeutics for $18.00 per share in cash and a
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Assertio Holdings, Inc. (NASDAQ: ASRT)
01:13pm, Thursday, 09'th Apr 2026
NEW YORK, April 9, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is
Does Assertio (ASRT) Have the Potential to Rally 115.05% as Wall Street Analysts Expect?
10:55am, Thursday, 09'th Apr 2026
The average of price targets set by Wall Street analysts indicates a potential upside of 115.1% in Assertio (ASRT). While the effectiveness of this highly sought-after metric is questionable, the posi
Cosette Pharmaceuticals Expands Branded Portfolio through Acquisition of SYMPAZAN® and Additional Products from Assertio
04:10pm, Wednesday, 08'th Apr 2026
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc., a U.S.-based, branded specialty pharmaceutical company, announced today the closing of a definitive agreement to acquire the U.S. sal
Assertio Announces Agreement to be Acquired by Garda Therapeutics
04:04pm, Wednesday, 08'th Apr 2026
LAKE FOREST, Ill.--(BUSINESS WIRE)--Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), today announced a definitive agreement (the “Garda Agreement”) to be acquired by G
Top 2 Health Care Stocks That May Implode In April
08:34am, Wednesday, 01'st Apr 2026
As of April 1, 2026, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Assertio (ASRT) Surges 17.9%: Is This an Indication of Further Gains?
09:35am, Wednesday, 25'th Mar 2026
Assertio (ASRT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in t
Wall Street Analysts Predict an 182.79% Upside in Assertio (ASRT): Here's What You Should Know
10:56am, Tuesday, 24'th Mar 2026
The average of price targets set by Wall Street analysts indicates a potential upside of 182.8% in Assertio (ASRT). While the effectiveness of this highly sought-after metric is questionable, the posi
Is Assertio (ASRT) Stock Outpacing Its Medical Peers This Year?
10:41am, Tuesday, 24'th Mar 2026
Here is how Assertio (ASRT) and BrightSpring Health Services, Inc. (BTSG) have performed compared to their sector so far this year.
Assertio (ASRT) Reports Q4 Loss, Beats Revenue Estimates
06:22pm, Monday, 16'th Mar 2026
Assertio (ASRT) came out with a quarterly loss of $1.86 per share versus the Zacks Consensus Estimate of a loss of $3.05. This compares to a loss of $1.65 per share a year ago.
Assertio Holdings, Inc. (ASRT) Q4 2025 Earnings Call Transcript
06:02pm, Monday, 16'th Mar 2026
Assertio Holdings, Inc. (ASRT) Q4 2025 Earnings Call Transcript
Assertio Reports Fourth Quarter and Full Year 2025 Financial Results
04:05pm, Monday, 16'th Mar 2026
LAKE FOREST, Ill--(BUSINESS WIRE)--Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differenti
Is Assertio (ASRT) Outperforming Other Medical Stocks This Year?
10:41am, Wednesday, 04'th Mar 2026
Here is how Assertio (ASRT) and Aura Biosciences, Inc. (AURA) have performed compared to their sector so far this year.
Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026
04:30pm, Tuesday, 03'rd Mar 2026
LAKE FOREST, Ill.--(BUSINESS WIRE)--Assertio Holdings, Inc. (“Assertio”) (Nasdaq: ASRT) today announced that it will release fourth quarter and full year 2025 financial results on Monday, March 16
